We expect price competition to continue and for voice revenue growth to moderate while data revenue grows.

FORBES: AT&T Rides Wireless Growth To $38 Stock Price

Generic competition to Topamax and Risperdal cut into sales, but strong growth from inflammatory disease treatment Remicade helped moderate the damage.

FORBES: The Band-Aid's Appeal To A Guy Like Benjamin Graham